Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Louisville, Kentucky


Purpose:

The goal of the study is to provide a detailed description of treatments for CRPC (Castrate Resistant Prostate Cancer) patients with bone metastases and the resource utilization and costs associated with that diagnosis and subsequent treatments.


Criteria:

Inclusion Criteria: - First diagnosis for bone metastases for members diagnosed with prostate cancer found in the claims data during the identification period - Members age ≥ 55 to 89 years at index - Medicare members with medical and pharmacy coverage; and - Continuously enrolled during the pre- and post-index periods. Exclusion Criteria: - Member with diagnosis of any other cancer (excluding melanoma (ICD-9 172.x) and other metastases (ICD-9 198.x)) before the index date; and - Members age ≥ 89 years of age at index date


NCT ID:

NCT02518698


Primary Contact:

Study Director
Bayer Study Director
Bayer


Backup Contact:

N/A


Location Contact:

Louisville, Kentucky
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: November 18, 2019

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.